MDD Augmentation: Buspirone

We continue our lecture series “10 Augmentation Strategies for MDD” with our seventh lecture on the role of Buspirone as an augmentation for major depressive disorder (MDD).

Let’s answer this question first:

Q: Which of the following guidelines recommend buspirone as first line for MDD augmentation?

Here is one slide from this presentation answering this question:

The role of Buspirone for MDD augmentation will be discussed in the following sections:

CHAPTER 7: BUSPIRONE FOR MDD AUGMENTATION

(FOR ACADEMY MEMBERS ONLY)
members only

INTERESTED IN LEARNING MORE?

JOIN ACADEMY’S FIRST LECTURE SERIES OF 2023:

PSYCHIATRY EDUCATION FORUM ACADEMY'S
JANUARY 2023 LECTURE SERIES ANNOUNCEMENT
(JAN 14 - JAN 29, 2023)

MAJOR DEPRESSIVE DISORDER:
10 AUGMENTATION STRATEGIES

Major Depressive Disorder: 10 Augmentation Strategies

JOIN HERE

JOIN ACADEMY MEMBERSHIP:

GENERAL
$ 99/YR
  •  
STUDENTS
$ 75/YR
  •  

DISCOUNTS AVAILABLE FOR: Residents & Students ONLY.

Email us your student information (program information and way to confirm your student status) to: HSingh@PsychiatryEducationForum.com

Related Articles